BUY Latent View Analytics Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)2 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·2 Nov · 5d ago
Latent View Analytics reported Q2FY27 revenue of 2,941 million, a 14.2% YoY increase, with an adjusted EBITDA margin of 20.7%.
BSE · Company Update·31 Oct · 6d ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Latent View Analytics
- BUY — Prabhudas Lilladher2 Nov 2026 · ~1 year · target ₹270 · Active
- BUY — Vikas Sethi, Sethi Finmart14 Oct 2026 · ~3 months · target ₹265 · SL hit
- BUY — Sandeep Jain, Tradeswift9 Oct 2026 · ~1 year · target ₹290 · Active
- BUY — Prakash Gaba15 Sept 2026 · ~2 weeks · target ₹270 · SL hit
- BUY — Prakash Gaba24 Aug 2026 · ~2 weeks · target ₹300 · SL hit
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

